The DOI matches its Crossref record; 138 of the 140 references it cites were found in a registry or an index.
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Open accessAbstract
Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly. Patients with AD suffer a gradual deterioration of memory and other cognitive functions, which eventually leads to a complete incapacity and death. A complicated array of molecular events has been implicated in the pathogenesis of AD. The major pathological characteristics of AD brains are the presence of senile plaques, neurofibrillary tangles, and neuronal loss. Growing evidence has demonstrated that oxidative stress is an important factor contributing to the initiation and progression of AD. However, the mechanisms that lead to the disruption of redox balance and the sources of free radicals remain elusive. The excessive reactive oxygen species may be generated from mechanisms such as mitochondria dysfunction and/or aberrant accumulation of transition metals, while the abnormal accumulation of Abeta and tau proteins appears to promote the redox imbalance. The resulted oxidative stress has been implicated in Abeta- or tau-induced neurotoxicity. In addition, evidence has suggested that oxidative stress may augment the production and aggregation of Abeta and facilitate the phosphorylation and polymerization of tau, thus forming a vicious cycle that promotes the initiation and progression of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the context of Aβ production, multiple investigations have revealed that oxidative stress leads to the formation of SPs by lowering α-secretase activity while increasing both βand γ-secretase activities [52].”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [52]
In the citing paper
“However, when the hyperphosphorylated Tau protein is overexpressed (which is a pathophysiological indicator of AD) a depletion of these organelles has been evidenced, suggesting it is the cause of H2O2 and ROS increase [72,108,126].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [126]
In the citing paper
“Hydrogen peroxide seems to be the relevant actor in promoting excessive oxidation in neuronal cells.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Flagged first, then by citations
2 of the 140 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 863
Brunetti, L., Leuci, R., Carrieri, A., Catto, M., Occhineri, S., Vinci, G., Gambacorta, L., Baltrukevich, H., Chaves, S., Laghezza, A., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114358 · Cited by 52
Nwidu, L. L., Elmorsy, E. M., Thornton, J., Wijamunige, B. C., Wijesekara, A., Tarbox, R., Warren, A. Y., & Carter, W. G. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1339283 · Cited by 53
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders
Akanji, M. A., Rotimi, D. E., Elebiyo, T. C., Awakan, O. J., & Adeyemı, O. S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9971885 · Cited by 55
Papakyriakopoulou, P., Manta, K., Kostantini, C., Kikionis, S., Banella, S., Ioannou, E., Christodoulou, E., Rekkas, D. M., Dallas, P. P., Vertzoni, M., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121016 · Cited by 53
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 57
Griebsch, L. V., Theiss, E. L., Janitschke, D., Erhardt, V. K. J., Erhardt, T., Haas, E. C., Kuppler, K. N., Radermacher, J., Walzer, O., Lauer, A. A., et al. (2023) · Nutrients · doi:10.3390/nu15061467 · Cited by 66
Lee, K. H., Lee, S., Lee, H. J., Choi, G. E., Jung, Y. H., Kim, D. I., Gabr, A. A., Ryu, J. M., & Han, H. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00229 · Cited by 57
Enzyme inhibitory and antioxidant properties of six mushroom species from the Agaricaceae family
Akata, İ., Zengin, G., Picot, C. M. N., & Mahomoodally, M. F. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.01.008 · Cited by 52
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
Coles, M., Steiner-Lim, G. Z., & Karl, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.962922 · Cited by 57
Antioxidant Polymers as Biomaterial
van Lith, R., & Ameer, G. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803269-5.00010-3 · Cited by 51
Mamsa, S. S. A., & Meloni, B. P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.759729 · Cited by 50
Kanamaru, T., Kamimura, N., Yokota, T., Iuchi, K., Nishimaki, K., Takami, S., Akashiba, H., Shitaka, Y., Katsura, K., Kimura, K., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.033 · Cited by 52
Nutrition and Alzheimer Disease
Fernández, S. S. M., & Ribeiro, S. M. L. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.012 · Cited by 50
Arumugam, R., Kırkan, B., & Sarıkürkçü, C. (2018) · South African Journal of Botany · doi:10.1016/j.sajb.2018.07.002 · Cited by 49
Peng, J.-J., Lin, S.-H., Liu, Y., Lin, H.-C., Li, T.-N., & Yao, C. (2019) · eLife · doi:10.7554/elife.47372 · Cited by 42
Caruso, G., Grasso, M., Fidilio, A., Torrisi, S. A., Musso, N., Geraci, F., Tropea, M. R., Privitera, A., Tascedda, F., Puzzo, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.809541 · Cited by 53
Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Cummings, J. L., Ortiz, A. A., Castellino, J., & Kinney, J. W. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15619 · Cited by 54
Bavarsad, N. H., Bagheri, S., Kourosh‐Arami, M., & Komaki, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18492 · Cited by 63
Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice
Fertan, E., Stover, K. R., Brant, M. G., Stafford, P. M., Kelly, B., Diez‐Cecilia, E., Wong, A. A., Weaver, D. F., & Brown, R. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01044 · Cited by 49
Pandey, S. N., Rangra, N. K., Singh, S., Arora, S., & Gupta, V. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00206 · Cited by 50
Barber, K., Mendonca, P., & Soliman, K. F. A. (2023) · Brain Sciences · doi:10.3390/brainsci13010145 · Cited by 51
TRPM2: bridging calcium and ROS signaling pathways—implications for human diseases
Maliougina, M., & Hiani, Y. E. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1217828 · Cited by 47
Nuzzo, D., Amato, A., Picone, P., Terzo, S., Galizzi, G., Bonina, F. P., Mulè, F., & Carlo, M. D. (2018) · Nutrients · doi:10.3390/nu10091130 · Cited by 47
Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus
Lindsay, C. B., Zolezzi, J. M., Rivera, D. S., Cisternas, P., Bozinovic, F., & Inestrosa, N. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01784-6 · Cited by 48
Xian, Y., Qu, C. F., Liu, Y., Ip, S., Yuan, Q., Yang, W., & Lin, Z. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5920476 · Cited by 48
Qu, L., Ji, L., Wang, C., Luo, H., Li, S., Peng, W., Yin, F., Lu, D., Liu, X., Kong, L., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113441 · Cited by 47
Applications of the Keap1–Nrf2 system for gene and cell therapy
Kanninen, K. M., Pomeshchik, Y., Leinonen, H. M., Malm, T., Koıstınaho, J., & Levonen, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.037 · Cited by 47
Guo, M., Wang, Z., Zhou, X., Yu, C., Wu, J., Yu, L., Mi, J., Ren, F., Law, B. Y. K., Pan, H., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156928 · Cited by 46
Bacchetti, T., Vignini, A., Giulietti, A., Nanetti, L., Provinciali, L., Luzzi, S., Mazzanti, L., & Ferretti, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143096 · Cited by 46
DNA Demethylation Upregulated Nrf2 Expression in Alzheimer’s Disease Cellular Model
Cao, H., Wang, L., Chen, B., Zheng, P., He, Y., Ding, Y., Deng, Y., Lu, X., Guo, X., Zhang, Y., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00244 · Cited by 46
MST1 Regulates Neuronal Cell Death via JNK/Casp3 Signaling Pathway in HFD Mouse Brain and HT22 Cells
Khan, M., Rutten, B. P. F., & Kim, M. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102504 · Cited by 45
Gomaa, A. A., Makboul, R. M., El-Mokhtar, M. A., Abdel-Rahman, E. A., Ahmed, I. A., & Nicola, M. A. (2019) · Cytokine · doi:10.1016/j.cyto.2018.10.017 · Cited by 45
Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients
Costa, M., Horrillo, R., Ortiz, A. M., Pérez, A., Mestre, A., Ruiz, A., Boada, M., & Grancha, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180243 · Cited by 45
Haddad, M., Perrotte, M., Landri, S., Page, A. Y. L., Fülöp, T., & Ramassamy, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181272 · Cited by 44
Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303007 · Cited by 45
McCabe, S. M., & Zhao, N. (2021) · Nutrients · doi:10.3390/nu13061833 · Cited by 45
Erythropoietin as a new therapeutic opportunity in brain inflammation and neurodegenerative diseases
Merelli, A., Czornyj, L. A., & Lazarowski, A. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.989321 · Cited by 44
Głowacka, P., Oszajca, K., Pudlarz, A. M., Szemraj, J., & Witusik‐Perkowska, M. (2024) · Nutrients · doi:10.3390/nu16142244 · Cited by 52
Leba, L., Brunschwig, C., Saout, M., Martial, K., Vulcain, E., Béreau, D., & Robinson, J.-C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018023 · Cited by 44
Inestrosa, N. C., Ríos, J. A., Cisternas, P., Tapia‐Rojas, C., Rivera, D. S., Braidy, N., Zolezzi, J. M., Godoy, J. A., Carvajal, F. J., Ardiles, Á. O., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12226 · Cited by 47
The Mitochondrial Epigenome: a Role in Alzheimer’s Disease?
Devall, M. A. M., Mill, J. S., & Lunnon, K. (2014) · Epigenomics · doi:10.2217/epi.14.50 · Cited by 45
Fouad, I. A., Sharaf, N. M., Abdelghany, R. M., & Sayed, N. S. E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00236 · Cited by 44
β-amyloid and Oxidative Stress: Perspectives in Drug Development
Caruso, G., Spampinato, S. F., Cardaci, V., Caraci, F., Sortino, M. A., & Merlo, S. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191209115431 · Cited by 45
Fani, G., Torre, C. E. L., Cascella, R., Cecchi, C., Vendruscolo, M., & Chiti, F. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04513-w · Cited by 44
Prevention of Oxidative Stress and Diseases by Antioxidant Supplementation
Martemucci, G., Portincasa, P., Centonze, V., Mariano, M., Khalil, M., & D‘Alessandro, A. G. (2022) · Medicinal Chemistry · doi:10.2174/1573406419666221130162512 · Cited by 48
Porres-Martínez, M., González‐Burgos, E., Carretero, M. E., & Gómez-Serranillos, M. P. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.03.002 · Cited by 43
Huang, J.-L., Jing, X., Tian, X., Qin, M.-C., Xu, Z., Wu, D., & Zhong, Z.-G. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8713561 · Cited by 43
Pandareesh, M. D., Chauhan, V. P. S., & Chauhan, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180361 · Cited by 43
Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
Patel, D. V., Patel, N. R., Kanhed, A. M., Patel, S. P., Sinha, A., Kansara, D. D., Mecwan, A. R., Patel, S. B., Upadhyay, P. N., Patel, K. B., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00226 · Cited by 45
Choi, J. R., Kim, J. H., Lee, S., Cho, E. J., & Kim, H. Y. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111571 · Cited by 43
Lin, Y.-W., Fang, C.-H., Yang, C.-Y., Liang, Y., & Lin, F. (2022) · Antioxidants · doi:10.3390/antiox11040727 · Cited by 45
Malta, S. M., Batista, L. L., Silva, H. C. G., Franco, R. R., Silva, M. H., Rodrigues, T. S., Correia, L. I. V., Martins, M. M., Venturini, G., Espíndola, F. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15297-1 · Cited by 47
Arora, R., & Deshmukh, R. R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0182-y · Cited by 42
Sawmiller, D. R., Li, S., Mori, T., Habib, A., Rongo, D., Delic, V., Bradshaw, P. C., Shytle, R. D., Sanberg, C. D., Bickford, P. C., et al. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00279 · Cited by 42
Singh, Y. P., Shankar, G., Jahan, S., Singh, G., Kumar, N., Barik, A., Upadhyay, P., Singh, L., Kamble, K., Singh, G. K., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116385 · Cited by 42
Porcellotti, S., Fanelli, F., Fracassi, A., Sepe, S., Cecconi, F., Bernardi, C., Cimini, A., Cerù, M. P., & Moreno, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/967203 · Cited by 41
Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer’s disease brainPreprint
Ding, Q., Shults, N. V., Harris, B. T., & Suzuki, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.08.331157 · Cited by 42
Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
Shi, Z., Chen, H., Zhou, X., Yang, W., & Lin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.952332 · Cited by 43
Cisternas, P., Lindsay, C. B., Salazar, P. L., Silva-Álvarez, C., Retamales-Ortega, R., Serrano, F. G., Vio, C. P., & Inestrosa, N. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.009 · Cited by 42
Zhao, Y., & Wang, C. (2015) · BioMed Research International · doi:10.1155/2015/174050 · Cited by 41
Self-citationJia, S., Wu, X., Li, X., Dai, X., Gao, Z., Zheng, L., Zheng, Q., & Sun, Y. (2016) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2016.1201811 · Cited by 41
Ellis, B., Hye, A., & Snowden, S. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141899 · Cited by 39
Yang, E.-J., Mahmood, U., Kim, H.-J., Choi, M., Choi, Y., Lee, J., Cho, J., Hyun, J. W., Kim, Y. S., Chang, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.016 · Cited by 42
Dan-qing, L., YuJie, G., ChengPeng, Z., Du, H., Yi, H., BiSheng, H., & Cao, Y. K. (2020) · Phytotherapy Research · doi:10.1002/ptr.6871 · Cited by 44
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Varesi, A., Campagnoli, L. I. M., Carrara, A., Pola, I., Floris, E., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2023) · Antioxidants · doi:10.3390/antiox12010180 · Cited by 51
Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease
Adalier, N., & Parker, H. (2016) · Antioxidants · doi:10.3390/antiox5040040 · Cited by 40
Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45
Lactuca capensis reverses memory deficits in Aβ1‐42‐induced an animal model of Alzheimer's disease
Postu, P. A., Noumedem, J. A. K., Cioancă, O., Hăncianu, M., Mihăşan, M., Ciorpac, M., Gorgan, L., Petre, B. A., & Hriţcu, L. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13299 · Cited by 40
Samal, J., Rebelo, A. L., & Pandit, A. S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.012 · Cited by 43
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development
Cervellati, C., Valacchi, G., Tisato, V., Zuliani, G., & Marsillach, J. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05875-5 · Cited by 40
Yan, J., Pang, Y., Zhuang, J., Lin, H., Zhang, Q., Han, L., Ke, P., Zhuang, J., & Huang, X. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00106 · Cited by 40
Role of oxidative stress in various diseases: Relevance of dietary antioxidants
Kumar, V., Khan, A. A., Tripathi, A., Dixit, P. K., & Bajaj, U. K. (2015) · The Journal of Phytopharmacology · doi:10.31254/phyto.2015.4213 · Cited by 40
Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease
Feng, S., Liu, Y., Zhou, Y., Shu, Z., Cheng, Z., Brenner, C., & Feng, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1245904 · Cited by 36
Kılıç, B., Bardakkaya, M., Sağkan, R. I., Aksakal, F., Shakila, S., & Doğruer, D. S. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106322 · Cited by 39
Barber, K., Mendonca, P., Evans, J. A., & Soliman, K. F. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310872 · Cited by 39
Daniele, S., Pietrobono, D., Fusi, J., Iofrida, C., Chico, L., Petrozzi, L., Gerfo, A. L., Baldacci, F., Galetta, F., Siciliano, G., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0523-5 · Cited by 41
Relation of Plasma Selenium and Lipid Peroxidation End Products in Patients With Alzheimer’s Disease
Chmátalová, Z., Vyhnálek, M., Laczó, J., Hort, J., POSPISILOVA, R., Pechová, M., & Skoumalová, A. (2017) · Physiological Research · doi:10.33549/physiolres.933601 · Cited by 39
Talebi, M., Kakouri, E., Talebi, M., Tarantilis, P. Α., Farkhondeh, T., İlgün, S., Pourbagher‐Shahri, A. M., & Samarghandian, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1923479 · Cited by 41
Yin, Z., Geng, X., Zhang, Z., Wang, Y., & Gao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746711 · Cited by 40
Nuclear glutaredoxin 3 is critical for protection against oxidative stress-induced cell death
Pham, K., Pal, R., Qu, Y., Liu, X., Yu, H. K., Shiao, S. L., Wang, X., Smith, E. O., Cui, X., Rodney, G. G., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.003 · Cited by 38
Oyeleke, M. B., & Owoyele, B. V. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.114997 · Cited by 38
Elmorsy, E. M., Al-Ghafari, A. B., Doghaither, H. A. A., Salama, M., & Carter, W. G. (2022) · Brain Sciences · doi:10.3390/brainsci12080975 · Cited by 39
Morroni, F., Sita, G., Tarozzi, A., Cantelli‐Forti, G., & Hrelia, P. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.033 · Cited by 38
Role of insulin resistance in Alzheimer’s disease
Cai, Z., Xiao, M., Chang, L., & Yan, L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9631-3 · Cited by 38
Swardfager, W., Yu, D., Scola, G., Cogo‐Moreira, H., Chan, P., Zou, Y. Z., Herrmann, N., Lanctôt, K. L., Ramirez, J., Gao, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.029 · Cited by 38
Penetration, distribution and brain toxicity of titanium nanoparticles in rodents' body: a review
Zeman, T., Loh, E., Čierný, D., & Šerý, O. (2018) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2017.0109 · Cited by 38
de Oliveira, J. S., Abdalla, F. H., Dornelles, G. L., Palma, T. V., Signor, C., Bernardi, J., Baldissarelli, J., Lenz, L. S., de Oliveira, V. A., Schetinger, M. R. C., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5090-6 · Cited by 38
Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
Ahmadian, N., Hejazi, S., Mahmoudi, J., & Talebi, M. (2018) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.5.307 · Cited by 42
Hou, L., Zhang, L., Hong, J., Zhang, D., Zhao, J., & Wang, Q. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8014 · Cited by 39
Caruso, G., Benatti, C., Musso, N., Fresta, C. G., Fidilio, A., Spampinato, G., Brunello, N., Bucolo, C., Drago, F., Lunte, S. M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050477 · Cited by 40
Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution
Vergara, C., Ordóñez‐Gutiérrez, L., Wandosell, F. G., Ferrer, I., del Rı́o, J. A., & Gavı́n, R. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8793-7 · Cited by 38
Ianniello, R. G., Ricciardi, A., Parente, E., Tramutola, A., Reale, A., & Zotta, T. (2014) · LWT · doi:10.1016/j.lwt.2014.10.020 · Cited by 37
Hebda, M., Bajda, M., Więckowska, A., Szałaj, N., Pasieka, A., Panek, D., Godyń, J., Wichur, T., Knez, D., Gobec, S., et al. (2016) · Molecules · doi:10.3390/molecules21040410 · Cited by 37
Alzheimer's Disease and NQO1: Is there a Link?
Chhetri, J., King, A. E., & Gueven, N. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170203095802 · Cited by 38
Queda, F., Calò, S., Gwizdała, K., Magalhães, J. D., Cardoso, S. M., Chaves, S., Piemontese, L., & Santos, M. A. (2021) · Molecules · doi:10.3390/molecules26061658 · Cited by 37
Clark, J., Kayed, R., Kayed, R., Abate, G., Kinnon, P., & Kinnon, P. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.835288 · Cited by 38
Botanical Sources for Alzheimer’s: A Review on Reports From Traditional Persian Medicine
Hosseinkhani, A., Sahragard, A., Namdari, A., & Zarshenas, M. M. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517717013 · Cited by 37
Aging modifies daily variation of antioxidant enzymes and oxidative status in the hippocampus
Lacoste, M. G., Ponce, I. T., Golini, R. L., Delgado, S. M., & Anzulovich, A. C. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.12.002 · Cited by 36
Ellison, E. M., Bradley‐Whitman, M. A., & Lovell, M. A. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0969-y · Cited by 36
Elfakhri, K. H., Abdallah, I. M., Brannen, A. D., & Kaddoumi, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.020 · Cited by 36
Metadata
- Authors
- Zhao, Y., & Zhao, B.
- Affiliations
- Harbin Institute of Technology (CN)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Zhao, Yan
- Zhao, Baolu
- ORCID
- Zhao, Yan
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC3745981
- OpenAlex
- W2141262291
- Cited by
- 855
- References
- 140
- Citations by year
- 2026: 47 · 2025: 61 · 2024: 82 · 2023: 78 · 2022: 80 · 2021: 83 · 2020: 76 · 2019: 71 · 2018: 64 · 2017: 64 · 2016: 53 · 2015: 54 · 2014: 36 · 2013: 5
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- Weihai Science and Technology Development Program (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- Harbin Institute of Technology (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- National Basic Research Program of China (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Alzheimer's disease, oxidative stress, redox imbalance, reactive oxygen species, free radicals, mitochondrial dysfunction, amyloid-beta, tau protein, neurofibrillary tangles, amyloid plaques, neurotoxicity, neurodegeneration, dementia
- MeSH terms
- Alzheimer Disease, Humans, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
